Form 8-K - Current report:
SEC Accession No. 0001493152-24-021628
Filing Date
2024-05-28
Accepted
2024-05-28 17:00:19
Documents
18
Period of Report
2024-05-22
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 58515
2 ex3-1.htm EX-3.1 2484
3 ex3-1_001.jpg GRAPHIC 275865
4 ex3-1_002.jpg GRAPHIC 341857
5 ex3-1_003.jpg GRAPHIC 90741
  Complete submission text file 0001493152-24-021628.txt   1268129

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE pwupu-20240522.xsd EX-101.SCH 4297
7 XBRL DEFINITION FILE pwupu-20240522_def.xml EX-101.DEF 27484
8 XBRL LABEL FILE pwupu-20240522_lab.xml EX-101.LAB 38262
9 XBRL PRESENTATION FILE pwupu-20240522_pre.xml EX-101.PRE 26104
22 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 7718
Mailing Address 1200 BROADWAY, FLOOR 3 NEW YORK NY 10038
Business Address 1200 BROADWAY, FLOOR 3 NEW YORK NY 10038 561-704-8527
PowerUp Acquisition Corp. (Filer) CIK: 0001847345 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41293 | Film No.: 24992829
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)